Mega Genomics Limited (HKG:6667)
Hong Kong · Delayed Price · Currency is HKD 7.20
-0.05 (-0.69%)
Mar 31, 2025, 3:45 PM HKT
Mega Genomics Revenue
In the year 2024, Mega Genomics had annual revenue of 164.23M CNY with 8.54% growth. Mega Genomics had revenue of 107.29M in the half year ending June 30, 2024, with 9.91% growth.
Revenue
164.23M CNY
Revenue Growth
+10.11%
P/S Ratio
9.24
Revenue / Employee
767.41K CNY
Employees
214
Market Cap
1.61B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 164.23M | 12.93M | 8.54% |
| Dec 31, 2023 | 151.30M | 5.57M | 3.82% |
| Dec 31, 2022 | 145.73M | -91.46M | -38.56% |
| Dec 31, 2021 | 237.19M | 33.97M | 16.71% |
| Dec 31, 2020 | 203.22M | 79.52M | 64.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WuXi XDC Cayman | 5.58B |
| Adicon Holdings | 2.98B |
| Kindstar Globalgene Technology | 998.42M |
| Yunkang Group | 706.95M |
| Biosino Bio-Technology and Science Incorporation | 246.61M |
| Guanze Medical Information Industry (Holding) | 161.70M |
| King International Investment | 77.50M |
| China Biotech Services Holdings | 76.93M |